o-Methoxycinnamaldehyde has been isolated and purified from powdered cinnamon. The compound inhibits the growth and toxin production of mycotoxinproducing fungi. The substance completely inhibited the growth of Aspergillus parasiticus and A. flavus at 100 ,tg/ml and A. ochraceus and A. versicolor at 200 ,ug/ml. It inhibited the production of aflatoxin B1 by over 90% at 6.25 ,tg/ml, ochratoxin A at 25 ,ug/ml, and sterigmatocystin at 50 ,ug/ml. The substance also displayed a strong inhibitory effect on the growth of five dermatophytoses species, e.g., Microsporum canis (minimum inhibitory concentration, 3.12 to 6.25 ,tg/ml).
However, no antibacterial effect was observed at concentrations as high as 50 sg/ml.
Antimicrobial substances contained in common spices have been intensively investigated (2-4, 11, 13-17) . Okazaki et al. extensively studied the microbial effects of over 1,300 species of higher plants in Japan, including herbal drugs, and 50 kinds of essential oils. The authors concluded that cinnamaldehyde (CA) exhibited the highest antifungal properties.
Frazier (7) has suggested that spices appear to be useful antimicrobial agents in preventing growth of undersirable organisms in food.
Hartung et al. (8) reported a decrease in the growth of Aspergillus parasiticus and aflatoxin production in raisin bread containing cinnamon when compared with breads not containing cinnamon.
Additionally, Bullerman (3) indicates that cinnamon in concentration as low as 0.02% inhibited mold growth and aflatoxin production in yeast extract sucrose broth. Hitokoto et al. (9) also reported that cinnamon inhibited growth of A. parasiticus, A. versicolor, A. ochraceus, and Fusarium solani.
Cinnamon contains 0.5 to 1.0% volatile oil composed mainly of CA (65 to 75%), eugenol (4 to 10%), cinnamic acid, and o-methoxycinnamaldehyde (OMCA) (10, [44] [45] [46] . Bullerman et al. (4) studied the inhibition of fungal growth and aflatoxin production by CA and eugenol and concluded that these compounds are the major antifungal substances of cinnamon oil.
The object of this study was to elucidate the properties of another antimicrobial substance -OMCA-isolated and purified from cinnamon, as well as its inhibitory effect on fungal growth and mycotoxin production.
MATERIALS AND METHODS
Powdered cinnamon. Powdered cinnamon (Cinamoni Cortex Pulveratus; Nippon Funmatsu Yakuhin & Co., Osaka, Japan) was commercially prepared in accordance with the Japanese pharmacopeia (47) .
Isolation and purification of antifungal substance isolated from cinnamon (OMCA). The purification scheme is shown in Fig. 1 . Powdered cinnamon weighing 1 kg was steeped in5 liters of chloroform at room temperature and allowed to stand for 2 h. The mixture was evaporated to dryness on a rotary evaporator (Tokyo Rikakikai Co., Ltd., Tokyo, Japan) to yield 25.3 g of residue. A 20-g quantity of the residue was dissolved in 100 ml of n-hexane, the resulting nhexane soluble fraction was then applied to a kieselgel 60 (70-230 mesh; E. Merck AG, Darmstadt, Germany) chromatographic column. The column (2 by 20 cm) was eluted with 150 ml each of n-hexane, benzene: chloroform (9:1), and chloroform. The benzene:chloroform fraction exhibiting fungal growth inhibition, was concentrated, redissolved in 10 ml of benzene, and applied to an aluminum oxide (90 active, neutral; E. Merck AG) chromatographic column. The column (2 by 16 cm) was washed first with 150 ml each of benzene and benzene:chloroform (9:1), and then eluted with 150 ml of chloroform. The chloroform eluate was vacuum evaporated to 10 ml. One of the chloroform concentrates was applied to preparative thin-layer chromatography (PTLC) with a kieselgel GF-254 plate (20 chromatograph-mass spectrometer and TLC.
Gas chromatography-mass spectrometry. The instrumentation used was the Hitachi RMU-6MG (Hitachi Ltd., Tokyo, Japan) with experimental conditions as follows: column, 1 m by 3 mm (ID), glass column packed with 5% dexsil/Chromosorb-W-AW; column temperature, 150 to 250°C; carrier gas, He; column pressure, 1.33 kg/cm; detector, TIM; ionization voltage, 70 eV.
Reagents. CA, cinnamyl alcohol, cinnamic acid, and eugenol were obtained from Wako Pure Chemicals Inc., Osaka, Japan. OMCA was synthesized from omethoxybenzaldehyde and acetaldehyde as described by Bertram and Kursten (1) .
Inhibitory effect of each fraction against mycotoxin-producing fungi. (i) Microorganisms. Four mycotoxin-producing fungi were used for antifungal evaluation: A. parasiticus NRRL-3000 and A. flavus ATCC-28539 (aflatoxin); A. ochraceus stA-15, originally isolated from the atmosphere (ochratoxin); and A. versicolor I-20-b isolated from dried small sardine (sterigmatocystin). Only A. flavus was used for the antifungal properties evaluation during the purification steps; however, all strains were used for the antifungal studies of the chloroform extract and the final product.
(ii) Fractions. The chloroform concentrate and dried, purified final product were diluted or dissolved (wt/vol) in methanol as applicable to make 10-fold or 2-fold dilutions, respectively. A 100-,ul sample of each diluted solution was added to separate test tubes containing 10 ml of each broth. Each fraction obtained during the purification process was dissolved in 100 ,ug of methanol and added to separate test tubes. The test tubes were sterilized at 110°C for 10 min before inoculation with the fungal spore suspensions.
(iii) Determination of antifungal activity. The antifungal and toxin production properties of each fraction were evaluated with the following media: low salt (SL) broth (43) and yeast extract-sucrose (YES) broth (5). The inoculum was prepared by growing the organism on potato dextrose agar (Eiken Chemical Co., Ltd., Tokyo, Japan) slants for approximately 7 days at 25°C. The spores were harvested by adding 10 ml of sterilized 0.1% Driwel (polyethylene glycol sorbitan monooleate; Fuji Photo Film Co., Ltd., Tokyo, Japan) solution and aseptically dislodging the spores with a sterile inoculating loop. The solution was filtered on a membrane filter (pore size, 8 .0 jm; Nihon Millipore Ltd., Tokyo, Japan). The spore suspension thus obtained was further adjusted with sterile Driwel solution to give a final concentration of approximately 104 spores per ml. The inoculum was 103 spores per ml (0.1 ml of the suspension). The cultures were incubated at 25°C in a slant for 8 days for aflatoxinproducing strains and for the ochratoxin-producing strain and 12 days for the sterigmatocystin-producing strain.
After the incubation, the culture was filtered through a glass filter (Shibata Chemical Apparatus Manufacturing Co., Ltd., Tokyo, Japan). The fungal mat was dried at 50°C for 48 h and then stored over silica gel for 1 week. The weight of the dried fungal mat was then determined. Mycotoxin production was evaluated by the methods of Eppley (6) and Naoi et al. (18) . The mycotoxin was extracted by adding 10 ml chloroform to the cunture and holding in a water bath at 400C. The extract was passed through anhydrous sodium sulfate and concentrated at 0.5 ml by evaporation. The mycotoxin concentration in the extract was determined by TLC. When necessary, additional cleanup was performed for aflatoxin and ochratoxin A as described by Eppley (6) . After addition of 1.5 ml of chloroform, 2 ml of the extract was applied to a kieselgel chromatographic column (1 by 13 cm) prepared by adding 2 g of sodium sulfate followed by 4 g of kieselgel 60 and topped off with another 2 g of sodium sulfate. The column was separately washed with acetone:benzene (5:95) and anhydrous ethylether and then eluted with 100 ml each of chloroform:methanol (97:3) and acetic acid:benzene (1:9) for aflatoxins and ochratoxin A, respectively. Separately, 2 ml of the chloroform extract was applied to a double layer of chromatographic column (1 by 20 cm) of 4 g of florisil (60 to 100 mesh; Sigma Chemical Co., St. Louis, Mo.) on top of 4 g of kieselgel. Sterigmatocystin was eluted from the column with 100 ml of benzene:methanol (9:1) after washing with 100 ml each of benzene:acetone (99:1) (18). The eluants were evaporated to dryness in an evaporator. The residues were dissolved in 0.5 ml of chloroform and applied to TLC plates for detection of each mycotoxin.
Adsorbosil-1 (0.25 thick; Applied Science Laboratories, State College, Pa.) was applied to each TLC plate and activated by heating at 80°C for 2 h. Ten to twenty microliters of each sample and the mycotoxin standard were spotted on a plate with a microsyringe. The plates were developed with chloroform:acetone (9:1) for aflatoxins and with benzene:acetic acid (9:1) for ochratoxin A (6), and benzene:methanol:acetic acid (9:1:5) for sterigmatocystin (18 Inhibitory effect of various fractions obtained during the purification process against growth and aflatoxin production by A. flavus. As shown in Table 2 , the n-hexane soluble fraction derived from the chloroform extract showed a strong inhibitory effect. This fraction was then applied to a kieselgel 60 chromatographic column to yield three fractions, of which the benzene:chloroform eluate showed a strong inhibition. This fraction was then vacuum concentrated in an evaporator and redissolved in benzene. The solution was applied to an aluminum oxide column and eluted sequentially (Fig. 2) . The TT-2 fraction proved to be a single compound, and its molecular weight was estimated to be 162. The mass spectrum and TLC properties of TT-2 were compared with those of OMCA (molecular weight, 162), methyl cinnamate (molecular weight, 162), eugenol (molecular weight, 164), and other compounds derived from cinnamon and having a molecular weight around 162. The mass spectrum and TLC properties of the TT-2 fraction were identical with those of OMCA. The element analyses and melting point measurements gave identical values. This confirms the previous observation of Karig (10) . The compound has the structure shown in Fig. 3 The mass spectrum of TT-1 fraction was compared with those of commercial CA, cinnamic acid, and cinnamic alcohol. They were identical, and thus the TT-1 fraction was identified as CA.
Inhibitory effect of OMCA against growth and toxin production by toxigenic fungi. As shown in Table 3 , OMCA inhibited the growth of both A. parasiticus and A. flavus at 100 ,tg/ml and the growth of both A. ochraceus and A. versicolor at 200 ,ug/ml. At 6.25 ,ug/ml, OMCA inhibited the toxin production by two aflatoxin-producing species to about 90%. About 90% inhibition of the toxin production by ochratoxin A-producing and sterigmatocystinproducing fungi was observed at 25 ug/ml and 50 ,ug/ml, respectively. The MIC of the CA fraction for A. flavus was about four times that of OMCA, i.e., 400,g/ml.
Antimicrobial effect of OMCA. Table 4 shows the MICs of OMCA against various bacteria, and Table 5 shows those against various fungi. OMCA completely inhibited the growth of S. aureus and C. botulinum at 200 and 100 ,ug/ml, respectively.
The MICs of OMCA for fungi are as follows: 3.12 ,ug/ml in M. canis; 6.25 ,ug/ml in T. mentagrophytes, T. rubrum, E. floceosum, and M. gypseum; 12.5 ,ug/ml in C. neoformans; 50 ,ug/ml in C. albicans; 100 ,ug/ml in A. fumigatus; and 200 ,ug/ml in A. niger. OMCA showed considerable inhibition against the five species of dermatophytoses in comparison with other fungi tested. DISCUSSION It has been reported that cinnamon oil contains CA, eugenol, cinnamic alcohol, cinnamic acid, linalool, and over 10 other compounds (10, (44) (45) (46) 1975, but its antimicrobial effect was not investigated at that time. By using comparative antimicrobial data of CA (MIC, 400 ,ug/ml), OMCA has the highest inhibitory effect (MIC, 100
,jg/ml) against growth of A. flavus. The OMCA inhibited the growth of three other strains of mycotoxin-producing fungi at concentrations from 100 to 200 ug/ml, and considerably inhibited the toxin production at concentrations from 6.23 to 50,g/ml. Moreover, it is very interesting that OMCA was effective only against S. aureus (MIC, 200 jig/ml) and C. botulinum (MIC, 100,ug/ml), but ineffective against other pathogenic bacteria (MIC, over 200 ,Ig/ml), although it showed pronounced growth-inhibiting effect against pathogenic fungi. The MIC for five species of dernatophytoses was 3.12 to 6.25 ,ug/ml.
Providing its toxigenicity is low, utilization of this compound may be expected as an antifungal agent in foods and as a treatment of dermatomycosis.
